The Evolving Practice of Cardiovascular Precision Medicine

The Evolving Practice of Cardiovascular Precision Medicine


Join us for The Evolving Practice of Cardiovascular Precision Medicine and equip yourself with foundational and operational knowledge of precision medicine and how to apply techniques to your clinical and research settings.

The course focuses on three key areas that are rapidly growing in clinical applications:

  • Genomic medicine in cardiovascular disease prevention and management
  • Machine learning applications in cardiovascular imaging
  • Integration of digital health tools for personalization of cardiovascular care

Register today and gain access to live educational sessions, real-time discussion opportunities with faculty, and On Demand sessions to watch at your convenience — 3 months of access until July 16, 2021!

Overview
The advent of high throughput technologies (genomics, metabolomics, proteomics) and big data analytics (machine learning, artificial intelligence), with the expansion of digital health tools, has ushered in the era of precision medicine in cardiovascular disease. The concept of personalizing therapies to maximize benefits and minimize risk for patients is within reach. While healthcare providers have overwhelmingly expressed interest in innovation and the transformation of medicine, most have had little to no exposure to the data, platforms, methods, and clinical applications that form the foundation of Precision Medicine.

Goal
The overall goal is to equip cardiovascular providers with the core knowledge and skills to understand and apply evidenced-based genomic medicine and digital technologies to patients at risk for and with established cardiovascular disease and to recognize the current limitations of each approach. Learners will acquire the knowledge to implement precision medicine strategies in clinical practice, research, and quality improvement initiatives and use applications of precision medicine in cardiovascular genomics, cardiac imaging, and clinical decision support.

Learning Objectives
Upon completion of this activity, learners should be able to:

  1. Understand the use of genomic risk prediction for cardiovascular disease prevention and management.
  2. Develop a framework for integrating ‘imaging’ and ‘mobile health’ sensors like ECG to develop ‘digital’ patient phenotypes for risk stratifications and interventions.
  3. Understand the opportunity in using “omics” data for routine assessment of cardiovascular diseases with a broad overview of the ethical, social, and regulatory challenges.
  4. Evaluate the risks and benefits of open source and commercially available platforms for precision medicine implementation in cardiology.
  5. Understand the difference between consumer grade and medical grade digital health devices and their application to disease detection, diagnosis, and monitoring.
  6. Understand the potential applications and limitations of machine learning in cardiovascular imaging.

Target Audience
The target audience is cardiovascular care providers (physicians, advanced practice providers, and nurses) interested in implementing precision medicine applications in their practice and translational cardiovascular researchers without prior expertise in omics and big data analytics, interested in expanding their skill set in those areas.

Course Directors

Regina Druz, MD, FACC
Director, Integrative Cardiology
St. Francis Hospital - New York

Akl C. Fahed, MD, MPH
Cardiologist and Scientist
Massachusetts General Hospital
Broad Institute of Harvard and MIT

Planning Committee

Geoffrey Ginsburg, Md, PhD, FACC
Professor and Director, Duke Center for Applied Genomics and Precision Medicine
Duke University School of Medicine

Evan Muse, MD, PhD, FACC
Associate Program Director for Research, Division of Cardiovascular Diseases
Scripps Clinic
Lead Cardiovascular Genomics
Scripps Research Translational Institute

Partho Sengupta, MD, FACC
Chief, Division of Cardiology
Director, Cardiovascular Imaging
Chair, Cardiovascular Innovation
West Virginia University Heart and Vascular Institute
Professor of Medicine
West Virginia University School of Medicine

Faculty

Themistocles (Tim) Assimes, MD, PhD
Associate Professor of Medicine
Stanford University School of Medicine

Nikki Batista, Meng
Director, Digital Health Regulatory Affairs
MCRA

John D. Halamka, MD, MS
President, Mayo Clinic Platform
Mayo Clinic

Carolyn Ho, MD, FACC
Medical Director, Cardiovascular Genetics Center
Brigham and Women's Hospital

Julie A. Johnson, PharmD
Dean and Distinguished Professor
University of Florida, College of Pharmacy

Amit V. Khera, MD, MSc
Group Leader, Center for Genomic Medicine
Massachusetts General Hospital
Associate Director of the Program in Medical and Population Genetics and Merkin Institute Fellow
Broad Institute of MIT and Harvard
Assistant Professor
Harvard Medical School

Claire Marblestone, Esq.
Partner
Foley & Lardner LLP

James Min, MD
CEO
Cleerly Health

David Ouyang, MD, FACC
Staff Physican, Smidt Heart Institute
Cedars-Sinai Medical Center

Eric Perakslis, PhD, MS
Chief Science and Digital Officer
Duke Clinical Research Institute

Michael Salerno, MD, PhD
Associate Professor of Medicine, Radiology, and BME
University of Virginia

Svati H. Shah, MD, MS, MHS
Professor of Medicine
Associate Dean of Genomics and Director of Precision Genomics Collaboratory
Director, Duke Adult Cardiovascular Genetics Clinic
Co-Director, Translational Research, Duke Molecular Physiology Institute
Vice-Chief, Translational Research, Division of Cardiology
Duke University School of Medicine

Jacqueline Shreibati, MD, MS, FACC
Clinical Lead, Senior Health Economics & Outcomes Researcher
Google Health

Amy Curry Sturm, MS
Genetic Counselor
Professor
Geisinger

Ali Torkamani, PhD
Associate Professor
Scripps Research

Neil Weissman, MD, FACC
Chief Scientific Officer
MedStar Health
President
MedStar Health Research Institute
Professor of Medicine
Georgetown University

Catherine A. Wicklund, MS
Director, Graduate Program in Genetic Counseling
Northwestern University

Naveena Yanamala, PhD
Principal Data Scientist
Adjunct Professor
West Virginia University
Adjunct Professor
Carnegie Mellon University

Clyde W. Yancy, MD, MSc, MACC
Vice Dean, Diversity & Inclusion
Magerstadt Professor of Medicine
Professor of Medical Social Sciences
Chief, Division of Cardiology
Northwestern University, Feinberg School of Medicine

Disclosure/Conflict of Interest Statement
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 12 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.

  • Online: Click the Register button at the top of the page
  • Phone: 800-253-4636, ext. 5603 or 202-375-6000, ext. 5603

Registration for The Evolving Practice of Cardiovascular Precision Medicine includes access to the livestream on April 16, 2021 and on-demand access to sessions and additional content through July 17, 2021.

Registration Fees
Rate Type Example Designations Early Until 3/19/2021 Regular After 3/20/2021
Member Physician (includes International Associate) MD, DO $199 $249
Non-member Physician MD, DO $299 $349
AACC/CCA Member (includes CVT Member, FIT, Resident, Student, Emeritus) PA, RN, NP, CNS, PharmD, FIT, Resident, Student and Emeritus $99 $149
CCA Non-member PA, RN, NP, CNS, PharmD, Resident, Student $199 $249
Industry Professional $299 $349

Cancellation
Cancellation, substitution, or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $50 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.

ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. In the unlikely event that the course is canceled, the College will refund the registration fee in full.

Joint Accreditation Statement

In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statement

Physicians
The ACCF designates this other activity (live virtual and on demand) for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.